Blueprint Medicines
BPMC
$108.55
Share price
2.16%
Change (1 day)
98.45%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Net assets
Net assets on the balance sheet as of December 2023 : $0.13 B
According to Blueprint Medicines
's latest financial reports the company has $0.13 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Blueprint Medicines - Net assets on balance sheet (from 2014 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | -74.62% |
| 2022-12-31 | $0.51 B | -46.98% |
| 2021-12-31 | $0.97 B | -33.97% |
| 2020-12-31 | $1.47 B | 216.58% |
| 2019-12-31 | $0.46 B | 10.82% |
| 2018-12-31 | $0.41 B | -32.85% |
| 2017-12-31 | $0.62 B | 192.84% |
| 2016-12-31 | $0.21 B | 47.99% |
| 2015-12-31 | $0.14 B | 306.39% |
| 2014-12-31 | $35.42 M | -2468.25% |
| 2013-12-31 | $-1.5 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $0.70 B | 436.95% | 🇺🇸 USA |
 OPKO Health
OPK | $1.38 B | 963.65% | 🇺🇸 USA |
 Isoray
ISR | $55 M | -57.88% | 🇺🇸 USA |